Renaissance Technologies
COYA icon

Renaissance Technologies’s Coya Therapeutics COYA Stock Holding History

Renaissance Technologies’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
103,964
+37,064
+55% +$173K ﹤0.01% 2681
2025
Q4 		$388K Buy
66,900
+32,100
+92% +$195K ﹤0.01% 2675
2025
Q3 		$198K Buy
34,800
+20,800
+149% +$127K ﹤0.01% 3135
2025
Q2 		$80.5K Buy
14,000
+1,800
+15% +$10.4K ﹤0.01% 3334
2025
Q1 		$78.9K Buy
+12,200
New +$77.2K ﹤0.01% 3227
2024
Q4 		– Sell
-17,200
Closed -$111K – 3622
2024
Q3 		$111K Buy
17,200
+500
+3% +$3.15K ﹤0.01% 3243
2024
Q2 		$101K Buy
+16,700
New +$134K ﹤0.01% 3182

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies's COYA Position: Q1 2026 in Review

Renaissance Technologies increased its Coya Therapeutics (COYA) stake by 55% in Q1 2026, buying an estimated $173K and bringing the position to 103,964 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Renaissance Technologies first reported a position in COYA in Q2 2024 and has held it in 7 quarters since. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Renaissance Technologies held 103,964 shares of Coya Therapeutics worth $410K as of Q1 2026.
  • Renaissance Technologies bought 37,064 Coya Therapeutics shares in Q1 2026, an estimated $173K.
  • Coya Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2681 holding.
  • Renaissance Technologies first reported a position in Coya Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.